The Australian Contract Research Organization Market

Early Phase Clinical Trials are Set to Drive the Australian CRO Market

USD 1,500.00

* Required Fields

USD 1,500.00


Be the first to review this product

This research service presents an overview and analysis of the Australian contract research organization (CRO) market. The research service provides market revenue forecasts by phase and therapeutic type and discusses major issues and challenges, unmet needs, and developing trends in the CRO market. The study covers the complete life cycle of the CRO industry, starting from preclinical trials to Phase IV trials and provides detailed information on support services such as central laboratory services, biostatistics, bioanalytics, and data management. The research service analyses market engineering measurements and research and development trends.

Table of Contents

The Australian Contract Research Organization MarketExecutive SummaryKey FindingsKey Findings (continued)Total CRO Market Size by Stages of Clinical DevelopmentMarket Size Estimation MethodologyScope and SegmentationKey Questions this Study will AnswerMarket Engineering MeasurementsCEO’s PerspectiveKey Companies to WatchKey Companies to Watch (continued)Market OverviewPharmaceutical Market OverviewPharmaceutical Market Overview (continued)Market PerspectiveClinical Trials—Market OverviewClinical Trials Market OverviewClinical Trials Market Overview (continued)Clinical Trials ScenarioProfiles of Clinical TrialsTotal CRO Market Segmentation by Stages of Clinical DevelopmentForecasts and Trends—Total CRO MarketForecast AssumptionsMarket Engineering MeasurementsTotal CRO Market—Revenue ForecastTotal CRO Market—Revenue Forecast DiscussionCRO Market—Phase I and Phase IICRO Market—Phase III and Phase IVCRO Market—Revenue Forecast for Preclinical TrialsRevenue Forecast Discussion for Preclinical TrialsCRO Market—Revenue Forecast for Data ManagementRevenue Forecast Discussion for Data ManagementCRO Market—Revenue Forecast for BiostatisticsRevenue Forecast Discussion for BiostatisticsCRO Market—Revenue Forecast for Central Laboratory ServicesRevenue Forecast Discussion for Central Laboratory ServicesCRO Market—Revenue Forecast for PharmacovigilanceRevenue Forecast Discussion for PharmacovigilanceCRO Market—Revenue Forecast for BioanalyticsRevenue Forecast Discussion for BioanalyticsCRO Market—Revenue Forecast for HEORRevenue Forecast Discussion for HEORTotal CRO Market—Key TrendsRegulatory EnvironmentClinical Research Regulatory OverviewClinical Research Regulatory Overview (continued) Clinical Research Regulatory ProcessCompetitive EnvironmentCompetitive StructureCompetitive Analysis—Selected Key Market ParticipantsCompetitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)The Last WordThe Last Word—DiscussionLegal DisclaimerAppendixList of ExhibitsList of Exhibits (continued)The Frost & Sullivan StoryThe Frost & Sullivan StoryValue Proposition: Future of Your Company & CareerGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation ExcellenceOur Blue Ocean Strategy

Related Research

Release Date : 12-Aug-2015

Region : Global

Release Date : 03-Aug-2015

Region : Africa

Release Date : 10-Mar-2015

Region : Latin America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.